New pill targets Hard-to-Treat lung cancer mutation
Disease control
Not yet recruiting
This trial tests an experimental daily pill, VS-7375, for people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12D. Participants must have already tried chemotherapy and an immunotherapy drug. The study looks at whether the drug can shri…
Phase: PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC